XVIVO Submits an IDE Application to US FDA for Its Innovative Heart Technology – a Significant Milestone
GOTHENBURG, SE / ACCESSWIRE / April 27, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)XVIVO proudly announces the filing of an Investigational...